These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 11086668

  • 1. Cerebrospinal fluid levels of monoamine compounds and cholecystokinin peptides after exposure to standardized barometric pressure.
    Eklundh T, Gunnarsson T, Ornhagen H, Nordin C.
    Aviat Space Environ Med; 2000 Nov; 71(11):1131-6. PubMed ID: 11086668
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK, Nordin C, Jönsson EG, Engberg G, Linderholm KR, Erhardt S.
    J Psychiatr Res; 2007 Nov; 41(1-2):144-51. PubMed ID: 16434056
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Monoamine compounds in cerebrospinal fluid of healthy subjects punctured without preceding strict bed rest: a pilot study.
    Eklundh T, Gunnarsson T, Nordin C.
    Neuropsychobiology; 2001 Jan; 43(1):5-10. PubMed ID: 11150891
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH.
    Biol Psychiatry; 2004 Sep 15; 56(6):418-26. PubMed ID: 15364040
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cholecystokinin peptides in cerebrospinal fluid: a study in healthy male subjects.
    Gunnarsson T, Eklundh T, Eriksson M, Qureshi GA, Sjöberg S, Nordin C.
    Regul Pept; 1997 Jan 15; 68(1):57-61. PubMed ID: 9094755
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Decreased lumbar cerebrospinal fluid levels of monoamine metabolites in vascular dementia.
    Wallin A, Blennow K, Edman A, Månsson JE.
    Int Psychogeriatr; 1996 Jan 15; 8(3):425-36. PubMed ID: 9116178
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR, Huang Y, Tate E, Stanley M, Noetzel MJ, Gospe SM, Banasiak K.
    Ann Neurol; 1995 Feb 15; 37(2):189-97. PubMed ID: 7531417
    [Abstract] [Full Text] [Related]

  • 17. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers.
    Alfredsson G, Wiesel FA, Tylec A.
    Biol Psychiatry; 1988 Apr 01; 23(7):689-97. PubMed ID: 2453224
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gradients of CSF monoamine metabolites: a comparison between male and female volunteers.
    Nordin C, Eklundh T, Fernström V, Swedin A, Zachau AC.
    J Psychiatr Res; 1995 Apr 01; 29(2):133-40. PubMed ID: 7545235
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.